Get the best of CNBC in your inbox
CNBC's David Faber and Carl Icahn, chairman, Icahn Enterprises, discuss corporate boards, a dysfunctional system, his impact as an activist investor and why what he does is important, as well as the use of poison pills to fend off activists. He also finds himself in the unusual position of defending Bill Ackman's recent efforts to partner with Valeant and acquire Allergan.
Discussing new technology in the Permian, growing market in North America, and higher earnings, with Dave Lesar, Halliburton chairman, president and CEO.
Paul Raines, GameStop CEO, discusses how its leadership in digital sales, market share, and ability to drive loyalty with rewards propels consumers to stay with the gaming store.
Santitarn Sathirathai, Head of Southeast Asia & India Economics Research at Credit Suisse, explains why it is important for the Bank of Thailand to leave interest rates on hold at 2 percent.
JJ Kinahan, Chief Strategist at TD Ameritrade, says Yum Brands is back "on the right path" after a 9 percent gain in China led by KFC.
Eddie Tam, CIO at Central Asset Investments, says China will see a slowdown for a long time as a trade-off for avoiding a hard landing in its economy.
Andy Green, advisor to the Manchester United Supporters Trust, says the Glazer family has to take "a lot of blame" for the "disaster" at the soccer club this season.
Bob Parker, senior advisor of investment, strategy and Research at Credit Suisse, says valuation of technology stocks is becoming "stretched" and there is a rotation into value stocks.
Samir Brikho, CEO of AMEC, says the geopolitical tension in Europe from the Ukraine crisis is "alarming" for energy security.